Howard W. Robin
2015
In 2015, Howard W. Robin earned a total compensation of $4.4M as President and Chief Executive Officer at Nektar Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $625,000 |
|---|---|
| Option Awards | $816,976 |
| Salary | $892,620 |
| Stock Awards | $2,099,236 |
| Other | $12,156 |
| Total | $4,445,988 |
Robin received $2.1M in stock awards, accounting for 47% of the total pay in 2015.
Robin also received $625K in non-equity incentive plan, $817K in option awards, $892.6K in salary and $12.2K in other compensation.
Rankings
In 2015, Howard W. Robin's compensation ranked 1,895th out of 13,638 executives tracked by ExecPay. In other words, Robin earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,895 out of 13,638 | 86th |
Division Manufacturing | 682 out of 5,187 | 87th |
Major group Chemicals And Allied Products | 245 out of 1,857 | 87th |
Industry group Drugs | 191 out of 1,531 | 88th |
Industry Pharmaceutical Preparations | 154 out of 1,179 | 87th |
Source: SEC filing on April 29, 2016.
Robin's colleagues
We found five more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2015.
2015
John Nicholson
Nektar Therapeutics
Chief Financial Officer
2015
Gil Labrucherie
Nektar Therapeutics
General Counsel
2015
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Manufacturing Operations
2015
Ivan Gergel
Nektar Therapeutics
Chief Medical Officer
2015
Stephen Doberstein
Nektar Therapeutics